Treatment of chronically FIV-infected cats with suberoylanilide hydroxamic acid

Antiviral Research

Volumn 108, Issue 1, 2014, Pages 74-78

  McDonnel, Samantha J ^a   Liepnieks, Molly L ^a   Murphy, Brian G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Animal model; Antilatency therapy; FIV; HDAC inhibitor; HIV; SAHA

Indexed keywords

VIRUS DNA; VIRUS RNA; VORINOSTAT; HYDROXAMIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAT DISEASE; CELL CULTURE; COCULTURE; CONTROLLED STUDY; DRUG BLOOD LEVEL; FELINE IMMUNODEFICIENCY VIRUS; FELINE IMMUNODEFICIENCY VIRUS INFECTION; FILTERS AND MEMBRANES; FOOD INTAKE; IN VIVO STUDY; LATENT VIRUS INFECTION; LENTIVIRUS INFECTION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION; ANIMAL; BLOOD; CAT; CELL LINE; DRUG EFFECTS; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; VIROLOGY; VIRUS ACTIVATION; VIRUS LATENCY;

ADMINISTRATION, ORAL; ANIMALS; CATS; CELL LINE; COCULTURE TECHNIQUES; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; HYDROXAMIC ACIDS; IMMUNODEFICIENCY VIRUS, FELINE; RNA, VIRAL; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 84902584474     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2014.05.014     Document Type: Article

References (24)

1. N.M. Archin, R. Bateson, M. Tripathy, A.M. Crooks, K.H. Yang, N.P. Dahl, M.F. Kearney, E.M. Anderson, J.M. Coffin, M.C. Strain, D.D. Richman, K.R. Robertson, A.D. Kashuba, R.J. Bosch, D.J. Hazuda, J.D. Kuruc, J.J. Eron, and D.M. Margolis HIV-1 expression within resting CD4 T-cells following multiple doses of vorinostat J. Infect. Dis. 2014 [Epub ahead of print]
2. L.R. Bisset, H. Lutz, J. Boni, R. Hofmann-Lehmann, R. Luthy, and J. Schupbach Combined effect of zidovudine (ZDV), lamivudine (3TC) and abacavir (ABC) antiretroviral therapy in suppressing in vitro FIV replication Antiviral Res. 53 2002 35 45 (Pubitemid 33001553)
3. J.N. Blankson, D. Persaud, and R.F. Siliciano The challenge of viral reservoirs in HIV-1 infection Annu. Rev. Med. 53 2002 557 593 (Pubitemid 34177896)
4. M.J. Burkhard, and G.A. Dean Transmission and immunopathogenesis of FIV in cats as a model for HIV Curr. HIV Res. 1 2003 15 29
5. N. Chomont, M. El-Far, P. Ancuta, L. Trautmann, F.A. Procopio, B. Yassine-Diab, G. Boucher, M.R. Boulassel, G. Ghattas, J.M. Brenchley, T.W. Schacker, B.J. Hill, D.C. Douek, J.P. Routy, E.K. Haddad, and R.P. Sekaly HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation Nat. Med. 15 2009 893 900
6. L. Colin, and C. Van Lint Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies Retrovirology 6 2009 111
7. S. Columba Cabezas, and M. Federico Sequences within RNA coding for HIV-1 Gag p17 are efficiently targeted to exosomes Cell. Microbiol. 15 2013 412 429
8. F. Courchamp, and D. Pontier Feline immunodeficiency virus: an epidemiological review C. R. Acad. Sci. III 317 1994 1123 1134
9. J.H. Elder, Y.C. Lin, E. Fink, and C.K. Grant Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV Curr. HIV Res. 8 2010 73 80
10. J.E. Fogle, W.A. Tompkins, B. Campbell, D. Sumner, and M.B. Tompkins Fozivudine tidoxil as single-agent therapy decreases plasma and cell-associated viremia during acute feline immunodeficiency virus infection J. Vet. Intern. Med. 25 2011 413 418
11. L. Geeraert, G. Kraus, and R.J. Pomerantz Hide-and-seek: the challenge of viral persistence in HIV-1 infection Annu. Rev. Med. 59 2008 487 501 (Pubitemid 351287951)
12. K. Imai, H. Togami, and T. Okamoto Involvement of histone H3 lysine 9 (H3K9) methyltransferase G9a in the maintenance of HIV-1 latency and its reactivation by BIX01294 J. Biol. Chem. 285 2010 16538 16545
13. L.I. Kanzaki, and D.J. Looney Feline immunodeficiency virus: a concise review Front. Biosci. 9 2004 370 377 (Pubitemid 38925467)
14. A.A. Lane, and B.A. Chabner Histone deacetylase inhibitors in cancer therapy J. Clin. Oncol. 27 2009 5459 5468
15. D.M. Margolis Mechanisms of HIV latency: an emerging picture of complexity Curr. HIV/AIDS Rep. 7 2010 37 43
16. D.M. Margolis Histone deacetylase inhibitors and HIV latency Curr. Opin. HIV AIDS 6 2011 25 29
17. S. McDonnel, E.E. Sparger, P.A. Luciw, and B. Murphy Transcriptional regulation of latent feline immunodeficiency virus in peripheral CD4+ T-lymphocytes Viruses 4 2012 878 888
18. S.J. McDonnel, E.E. Sparger, P.A. Luciw, and B.G. Murphy Pharmacologic reactivation of latent feline immunodeficiency virus ex vivo in peripheral CD4+ T-lymphocytes Virus Res. 170 2012 174 179
19. S.J. McDonnel, E.E. Sparger, and B.G. Murphy Feline immunodeficiency virus latency Retrovirology 10 2013 69
20. S.J. McDonnel, L.A. Tell, and B.G. Murphy Pharmacokinetics and pharmacodynamics of suberoylanilide hydroxamic acid in cats J. Vet. Pharmacol. Ther. 37 2014 196 200
21. B. Murphy, N. Vapniarsky, C. Hillman, D. Castillo, S. McDonnel, P. Moore, P.A. Luciw, and E.E. Sparger FIV establishes a latent infection in feline peripheral blood CD4+ T lymphocytes in vivo during the asymptomatic phase of infection Retrovirology 9 2012 12
22. K. Patel, S.M. Guichard, and D.I. Jodrell Simultaneous determination of decitabine and vorinostat (suberoylanalide hydroxamic acid, SAHA) by liquid chromatography tandem mass spectrometry for clinical studies J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 863 2008 19 25
23. D.D. Richman, D.M. Margolis, M. Delaney, W.C. Greene, D. Hazuda, and R.J. Pomerantz The challenge of finding a cure for HIV infection Science 323 2009 1304 1307
24. D. Trono, C. Van Lint, C. Rouzioux, E. Verdin, F. Barre-Sinoussi, T.W. Chun, and N. Chomont HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals Science 329 2010 174 180